Suchergebnisse - "Puxeddu, Ermanno"

PubPharm (6)

1

Efficacy and cardiovascular safety profile of dual bronchodilation therapy in chronic obstructive pulmonary disease : A bidimensional comparative analysis across fixed-dose combinations

enthalten in: Pulmonary pharmacology & therapeutics | 2019

von Rogliani, P. | Matera, M. | Ritondo, B. | +4

2

Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease : a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine

enthalten in: Respiratory research | 2019

von Rogliani, P. | Matera, M. | Page, C. | +3

3

A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD

enthalten in: Expert opinion on drug safety | 2018

von Matera, M. | Calzetta, L. | Puxeddu, E. | +2

4

Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD : A pilot study

enthalten in: Pulmonary pharmacology & therapeutics | 2018

von Rogliani, P. | Ora, J. | Puxeddu, E. | +4

5

Onset of action of budesonide/formoterol Spiromax(®) compared with budesonide/formoterol Turbuhaler(®) in patients with COPD

enthalten in: Pulmonary pharmacology & therapeutics | 2016

von Cazzola, M. | Ora, J. | Di Paolo, A. | +3

6

Structured multidisciplinary discussion of HRCT scans for IPF/UIP diagnosis may result in indefinite outcomes

enthalten in: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG | 2015

von Pezzuto, G. | Claroni, G. | Puxeddu, E. | +8

1
[1]